Influence of subclinical hypothyroidism on parameters of tear production in patients with hypertension
DOI:
https://doi.org/10.14739/2310-1210.2018.5.141728Keywords:
hypertension, subclinical hypothyroidism, Schirmer testAbstract
A high incidence, continuous growth rates as well as collected data on modifying influence of subclinical hypothyroidism (SH) on cardiovascular disease, necessitate the improvement of clinical diagnostic methods of hypothyroidism at the early stages. Thyroid hypofunction has been proved to be influential in the tear fluid secretion and dry eye syndrome development. However, there is insufficient evidence of tear production parameters use for hypothyroidism diagnosis at the preclinical stages in patients with cardiovascular disease.
The aim of the work – to improve the diagnostics of SH in hypertensive patients by examining tear production parameters using the Schirmer test.
Materials and methods. 102 patients with essential hypertension stage II were enrolled in the study after signing an informed consent. Depending on the thyroid stimulating hormone (TSH) level patients were divided into 2 groups - with normal (0.4–4.0 mU\ml) and moderately increased level of TSH (4.0–15.6 mU\ml with normal levels of thyroid hormones). The group of hypertensive patients without SH included 71 patients (83.1 % of women (59) and 16.9 % of men (12)), the group of hypertensive patients with concomitant SH consisted of 31 patients (90.32 % of women (28) and 9.68 % of male, (3)). Patient groups were matched for age (55.11 ± 8.67 years versus 58.09 ± 10.04 years; P = 0.131), gender (P = 0.363), height (P = 0.821), weight (P = 0.832), body surface area (P = 0.780), body mass index (P = 0.885). Apart from laboratory thyroid screening (TSH, Free T4), all patients underwent the Schirmer test according to the standard procedure. There were conducted ROC-analysis, univariate logistic regression analysis, Bland-Altman analysis; the Mann-Whitney U-test and χ2 were used.
Results. The average levels of TSH in hypertensive patient groups with euthyroidism and SH were 1.98 ± 0.82 mU\ml and 7.12 ± 2.96 mU\ml (P = 0.0001), the Schirmer test mean values – 20.02 ± 8.8 mm and 8.45 ±7.66 mm (P = 0.0001), respectively. According to the ROC-analysis the critical value of Schirmer test was indicator of13 mm (sensitivity 93.7%, specificity 69.6 %, AUC 0.853; 95 % CI 0.703–0.945; P = 0.0001). Univariate logistic regression analysis has shown that in patients with hypertensive disease the Schirmer test values ≤13 mm increased odds ratio for SH by 21.44 times (95 % CI 3.76–312.72, P = 0.0017). Results of Bland-Altman analysis have demonstrated high consistency of the data obtained by different methods of SH diagnosis.
Conclusions. In hypertensive patients with concomitant SH a decrease in tear production according to the Schirmer test has been detected. The Schirmer test value of less than13 mm per 5 minutes should be considered as a criterion for SH diagnosis in hypertensive patients. Application of Bland-Altman method in comparing two methods of diagnosis allows using the Schirmer test for screening (prior to TSH levels determination) in patients with hypothyroidism as an additional factor of cardiovascular risk in patients with arterial hypertension.
References
Kovalenko, V. M., & Dorohoi, A. P. (2016). Sertsevo-sudynni khvoroby: medyko-sotsialne znachennia ta stratehiia rozvytku kardiolohii v Ukraini [Cardiovascular disease: medical and social importance and strateniya of Cardiology in Ukraine]. Ukrainskyi kardiolohichnyi zhurnal, 3, 5–14. [in Ukrainian].
Mathers, C. D., & Loncar, D. (2006). Projections of Global Mortality and Burden of Disease from 2002 to 2030. PLOS Medicine, 3(11), e442. doi: 10.1371/journal.pmed.0030442.
World Health Organization. (2014). Global status report on noncommunicable diseases.
Kvitashvili, O. (2015). Shchorichna dopovid pro stan zdorovia naselennia, sanitarno-epidemichnu sytuatsiiu ta rezultaty diialnosti systemy okhorony zdorovia Ukrainy. 2014 rik [Annual report on the state of health, sanitary and epidemiological situation and the results of the health system in Ukraine. 2014]. Kyiv. [in Ukrainian].
Horbas, I. M. (2008). Epidemiolohiia osnovnykh faktoriv ryzyku sertsevo-sudynnykh zakhvoriuvan [Epidemiology of the main risk factors for cardiovascular disease]. Arterialnaнa gipertenziya, 2(2). Retrieved from http://www.mif-ua.com/archive/article/6228 [in Ukrainian].
Ford, E. S., & Capewell, S. (2011). Proportion of the decline in cardiovascular mortality disease due to prevention versus treatment: public health versus clinical care. Ann. Rev. Public Health, 32, 5–22. doi: 10.1146/annurev-publhealth-031210-101211.
Frisoli, T. M., Schmieder, R. E., Grodzicki, T., & Messerli, F. H. (2011). Beyond salt: lifestyle modifications and blood pressure. European Heart Journal, 32(24), 3081–3087. doi: 10.1093/eurheartj/ehr379.
Gorodinskаyа, О., & Bobyrova, L. (2016). Prognostychna kharakterysyka poshyrennia hipotireozu v Poltavskii oblasti ta v Ukraini v tsilomu za umov yodnoho defitsytu [Prognostic characteristics of the prevalence of hypothyroidism in the Poltava region and in Ukraine under conditions of iodine deficiency]. Mizhnarodnyi endykrynolohichnyi zhurnal, 2, 44–49. [in Ukrainian].
Aoki, Y., Belin, R. M., Clickner, R., Jeffries, R., Phillips, L., & Mahaffey, K. R. (2007). Serum TSH and Total T4 in the United States Population and Their Association With Participant Characteristics: National Health and Nutrition Examination Survey (NHANES 1999–2002). Thyroid, 17(12), 1211–1223. doi: 10.1089/thy.2006.0235.
Pankiv, V. I. (2011). Praktychna tyreidolohiia. [Practice tireoidology]. Donetsk, Vydavets Zaslavskyi. [in Ukrainian].
Zaremba, Ye. Kh., & Shatynska-Mytsyk, I. S. (2010). Subklinichnyi hipotyreoz: laboratornyi fenomen chy okrema nozolohiia? [Subclinical hypothyroidism: a laboratory phenomenon or a specific nosology?]. Mystetstvo likuvannia, 2, 52–55. [in Ukrainian].
Kononenko, A. H., & Kravchenko, V. H. (2016). Zminy pokaznykiv obminu rechovyn pry eksperymentalnomu hipotyreozi [Changes in metabolic rate in experimental hypothyroidism]. Mizhnarodnyi endykrynolohichnyi zhurnal, 2, 174. [in Ukrainian].
Kadzharyan, V. G., Melnik, A. I., Bidzilya, P. P., & Solovyuk, S. A. (2014). Otsinka stanu lipidnoho obminu pid chas dysfunktsii shchytovudnoi zalozu [Assessment of the state of lipid exchange in thyroid dysfunction]. Zaporozhye medical journal, 1, 20–22. [in Ukrainian].
Podzolkov, A. V., & Fadeyev, V. V. (2009). Gipotireoz, subklinicheskij gipotireoz, vysokonormal'nyi uroven' TTG [Hypothyroidism, Subclinical Hypothyroidism, High-normal TSH-level]. Klinicheskaya i e'ksperimental'naya tireoidologiya, 5(2), 4–16. [In Russian].
Malyszko, J., Malyszko, J., Pawlak, K., & Mysliwiec, M. (2007). Thyroid Function, Endothelium, and Inflammation in Hemodialyzed Patients: Possible Relations? Journal Of Renal Nutrition, 17(1), 30–37. doi: 10.1053/j.jrn.2006.07.003.
Nekrasova, T. A., Strongin, L. G., Morozova, E. P., Durigina, E. M., & Kasakova, L. V. (2015). Modificiruyushchee vliyanie subklinicheskogo gipotireoza na techenie arterial'noj gipertenzii vzaimosvyazi so skrytoj neeffektivnost'yu lecheniya sutochnym profilem arterial'nogo davleniya i sostoyaniem organov-mishenej. [Modifying influence of subclinical hypothyroidism on arterial hypertension: relationship to masked treatment failure, circadian blood pressure profile and target organs status]. Klinicheskaya i e'ksperimental'naya tireoidologiya, 11(2), 55–62. [in Russian]. doi: 10.14341/ket2015255-62.
Svare, A., Nilsen, T. I., Bjøro, T., Asvold, B. O., & Langhammer, A. (2011) Serum TSH related to measures of body mass: longitudinal data from the HUNT Study, Norwey. Clin. Endocrinol., 74(6), 769–775. doi: 10.1111/j.1365-2265.2011.04009.x.
Lohvynenko, A. O., Mitchenko, O. I., Romanov, V. Yu., Iliushyna, H. Ya., Beliaieva, T. V., & Chulaievska, I. V. (2009). Osoblyvosti lipidnoho ta vuhlevodnoho obminu u khvorykh z metabolichnym syndromom ta dysfunktsiieiu shchytopodibnoi zalozy [Features of lipid and carbohydrate metabolism in patients with metabolic syndrome and dysfunction of the thyroid gland]. Eurolab. Retrieved from https://www.eurolab.ua/encyclopedia/565/44670/ [in Ukrainian].
Dravica, L. V., Biryukov, F. I., Samokhvalova, N. M., et al. (2014). Korrekciia sindroma sukhogo glaza u pacientov s patologiei shchitovidnoj zhelezy [Correction of the «dry eye» syndrome in patients with thyroid gland pathology]. Proceedings of the 13th Congress of Ophthalmologists of Ukraine. (P. 10). Odessa.[in Russian].
Pavlovska, H. Ya., Pavliv, O. B., Pavlovskyi, M. I., & Pater, S. Ya. (2014). Sukhyi keratokoniunktyvit u khvorykh z hipotyreozom [Dry keratoconjunctivitis in patients with hypothyroidism]. Proceedings of the 13th Congress of Ophthalmologists of Ukraine. (P. 34). Odessa. [in Ukrainian].
Shashikala, P. (2013). Prevalence of dry eye in hypothyroidism. Int. J. Clin. Cases Investigations, 5(1), 46–51.
Bensenor, I. M., Olmos, R. D., & Lotufo, P. A. (2012). Hypothyroidism in the elderly: diagnosis and management. Clinical Interventions in Aging, 7, 97–111. doi: 10.2147/CIA.S23966.
Dias, A. C., Módulo, C. M., Jorge, A. G., Braz, A. M., Jordão, A. A. Jr., Filho, R. B., et al. (2007). Influence of Thyroid Hormone on Thyroid Hormone Receptor β-1 Expression and Lacrimal Gland and Ocular Surface Morphology. Investigative Opthalmology & Visual Science, 48(7), 3038–4108. doi: 10.1167/iovs.06-1309.
Drozhzhyna, H. I. (2011). Koniunktyvity [Conjunctivitis]. Odesa: Astroprynt. [In Ukrainian].
Petrunia, A. M., Mukham, E. A. (2012). Vplyv tiolovykh preparativ (atsetyltsysteina ta vitaiodurola) na systemu hliutatiuna v rohivtsi pry keratyti v poiednanni z koniunktyvitom [Influence of thiol agents (acetylcysteine and vitadiore) on the glutathione system in the cornea with keratitis in conjunction with conjunctivitis]. Ukrainskyi medychnyi almanakh, 15, 133–137.[in Ukrainian].
Gatzioufas, Z., Panos, G., Brugnolli, E., & Hafezi, F. (2014). Corneal Topographical and Biomechanical Variations Associated With Hypothyroidism. Journal of Refractive Surgery, 30(2), 78–79. doi: 10.3928/1081597x-20140120-01.
Micali, A., Pisani, A., Puzzolo, D., Spinella, R., Roszkowska, A., & Aragona, P. (2011). Effect of hypothyroidism on postnatal conjunctival development in rats. Ophthalmic Res., 45(2), 102–12. doi: 10.1159/000317065.
Mohanty, S., Amruthlal, W., Reddy, G., Kusumanjali, G., Kanagasabapathy, A., & Rao, P. (2008). Diagnostic strategies for subclinical hypothyroidism. Indian Journal Of Clinical Biochemistry, 23(3), 279–282. doi: 10.1007/s12291-008-0062-y.
Ozturk, B., Kerimoglu, H., Dikbas, O., Pekel, H., & Gonen, M. (2009). Ocular changes in primary hypothyroidism. BMC Research Notes, 2(1), 266. doi: 10.1186/1756-0500-2-266.
Petruela, M., Muresan, А., & Dimcea, I. (2012). Antioxidant Status in Hypo- and Hyperthyroidism. Antioxidant Enzymes. licensee InTech, 8, 197–236. http://dx.doi.org/10.5772/51018.
Plummer, C. E., Specht, А., & Gelatt, K. (2007). Ocular manifestations of endocrine disease. Compend Contin Educ., 29(12), 733–743.PMID: 18225637
Custro, N., Scafidi, V., Lo Baido, R., Nastri, L., Abbate, G., Cuffaro, M. P., et al. (1994). Subclinical hypothyroidism resulting from autoimmune thyroiditis in female patients with endogenous depression. J. Endocrinol. Iinvestig., 17, 641–646. doi: 10.1007/BF03349679.
Kahaly, G. (2000). Cardiovascular and Atherogenic Aspects of Subclinical Hypothyroidism. Thyroid, 10(8), 665–679. doi: 10.1089/10507250050137743.
Luboshitzky, R., Aviv, A., Herer, P., & Lavie, L. (2002). Risk Factors for Cardiovascular Disease in Women with Subclinical Hypothyroidism. Thyroid, 12(5), 421–425. doi: 10.1089/105072502760043512.
Cushing, G. W. (1993). Subclinical hypothyroidism. Understanding is the key to decision making. Postgrad Med., 94(1), 95–97, 100–102, 106–107. doi: 10.1080/00325481.1993.11945681.
Downloads
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)
